Available Intelligence Reports
TP53 Patent Landscape 2025
Comprehensive analysis revealing 847 patent opportunities with $4.2B market potential and 62% whitespace in tumor suppressor mechanisms.
EGFR Patent Landscape 2025
Strategic analysis highlighting $28.3B CNS penetration opportunity with 45% whitespace in brain-penetrant EGFR inhibitors.
KRAS Patent Landscape 2025
G12C breakthrough analysis revealing $15.8B market potential with 73% whitespace in non-G12C mutation targeting strategies.
PD-1 Patent Landscape 2025
Immunotherapy market analysis covering $47.2B market with 78% clinical success rate and 38% combination therapy whitespace.